Profile | GDS4284 / 221079_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1269.2 | 77 |
GSM687648 | Patient 402 control | 860.021 | 72 |
GSM687653 | Patient 403 control | 1264.73 | 78 |
GSM687658 | Patient 404 control | 1095.13 | 75 |
GSM687663 | Patient 411 control | 1451.41 | 79 |
GSM687668 | Patient 422 control | 1404.98 | 79 |
GSM687673 | Patient 424 control | 1327.42 | 78 |
GSM687678 | Patient 425 control | 1289.1 | 77 |
GSM687683 | Patient 427 control | 1166.64 | 76 |
GSM687688 | Patient 428 control | 916.969 | 73 |
GSM687695 | Patient 441 control | 347.04 | 53 |
GSM687699 | Patient 443 control | 1014.09 | 74 |
GSM687704 | Patient 444 control | 1048.6 | 75 |
GSM687707 | Patient 448 control | 2211.76 | 86 |
GSM687712 | Patient 449 control | 1027.73 | 75 |
GSM687719 | Patient 450 control | 1347.49 | 78 |
GSM687724 | Patient 451 control | 1469.43 | 80 |
GSM687728 | Patient 452 control | 1203.74 | 77 |
GSM687646 | Patient 401 treated 24h | 1628.22 | 81 |
GSM687649 | Patient 402 treated 24h | 1016.58 | 74 |
GSM687665 | Patient 411 treated 24h | 1222.05 | 77 |
GSM687651 | Patient 402 treated 4 weeks | 1227.78 | 77 |
GSM687667 | Patient 411 treated 4 weeks | 1449.81 | 79 |
GSM687670 | Patient 422 treated 24h | 1681.75 | 81 |
GSM687671 | Patient 422 treated 4 weeks | 1496.66 | 80 |
GSM687654 | Patient 403 treated 24h | 1221.52 | 77 |
GSM687675 | Patient 424 treated 24h | 1472.47 | 80 |
GSM687685 | Patient 427 treated 24h | 1153.59 | 76 |
GSM687656 | Patient 403 treated 4 weeks | 1258.13 | 77 |
GSM687677 | Patient 424 treated 4 weeks | 1530.14 | 80 |
GSM687687 | Patient 427 treated 4 weeks | 1230.76 | 77 |
GSM687692 | Patient 428 treated 4h | 1072.9 | 75 |
GSM687716 | Patient 449 treated 4h | 952.847 | 73 |
GSM687722 | Patient 450 treated 4h | 721.606 | 69 |
GSM687680 | Patient 425 treated 24h | 1254.18 | 77 |
GSM687690 | Patient 428 treated 24h | 1001.53 | 74 |
GSM687700 | Patient 443 treated 24h | 763.141 | 69 |
GSM687705 | Patient 444 treated 24h | 977.609 | 74 |
GSM687714 | Patient 449 treated 24h | 1264.87 | 78 |
GSM687721 | Patient 450 treated 24h | 792.729 | 70 |
GSM687682 | Patient 425 treated 4 weeks | 1219.35 | 77 |
GSM687694 | Patient 428 treated 4 weeks | 1148.86 | 76 |
GSM687702 | Patient 443 treated 4 weeks | 1265.34 | 77 |
GSM687718 | Patient 449 treated 4 weeks | 985.928 | 74 |
GSM687723 | Patient 450 treated 4 weeks | 1082.66 | 75 |
GSM687661 | Patient 404 treated 4h | 1229.46 | 77 |
GSM687710 | Patient 448 treated 4h | 2124.62 | 85 |
GSM687726 | Patient 451 treated 4h | 1408.24 | 79 |
GSM687730 | Patient 452 treated 4h | 354.723 | 46 |
GSM687660 | Patient 404 treated 24h | 597.539 | 67 |
GSM687697 | Patient 441 treated 24h | 650.209 | 67 |
GSM687709 | Patient 448 treated 24h | 2684.79 | 88 |
GSM687725 | Patient 451 treated 24h | 1388.29 | 79 |
GSM687729 | Patient 452 treated 24h | 792.776 | 72 |
GSM687727 | Patient 451 treated 4 weeks | 1400.94 | 79 |
GSM687731 | Patient 452 treated 4 weeks | 1497.29 | 80 |